跳至主要内容
临床试验/NCT05801757
NCT05801757已完成不适用

Sedative Effect of Remidazolam Besylate Continuous Pump Infusion for Colonoscopic Polypectomy in Elderly Patients

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2023年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
114
试验地点
1
主要终点
Sedation success rate

研究概览

简要总结

To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy.

详细描述

To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy, and to screen the optimal dose of remidazolam, in order to provide a more reasonable and safe sedative and analgesic drug regimen for elderly outpatients undergoing colonoscopic polypectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Single blind

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 60-80 years old;
  • ASA Level I - III;
  • Operation time: 15min~1h;
  • BMI18.0-29.9;

排除标准

  • Emergency surgery;
  • Patients with high risk of gastric satiety and reflux aspiration;
  • Allergies to benzodiazepines and opioids;
  • Those who have taken sedative, analgesic, or antidepressant drugs within 24 hours;
  • Abnormal liver and kidney function;
  • Previous drug use history;
  • Recently participated in other clinical studies;
  • Patients who cannot cooperate with communication.

研究组 & 干预措施

Propofol group

Active Comparator

propofol 2-3mg/kg/h

干预措施: Propofol (Drug)

R1 group

Experimental

remimazolam 0.5mg/kg/h

干预措施: Remimazolam (Drug)

R2 group

Experimental

remimazolam 0.75mg/kg/h

干预措施: Remimazolam (Drug)

结局指标

主要结局

Sedation success rate

时间窗: 1 day

Evaluating the success rate of sedation using the modified MOAA/S scoring table

次要结局

  • Intraoperative time record(Intraoperative)
  • Drug usage(1 day)
  • The incidence of adverse reactions during surgery(1 day)
  • Incidence of postoperative adverse reactions(24 hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

aijun xu

Doctor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验